Federal Register #2026-08990

FMCSA Renews Exemptions for Drivers with Epilepsy and Seizure Disorders

This notice from the Federal Motor Carrier Safety Administration (FMCSA) addresses the renewal of regulatory exemptions for commercial drivers with epilepsy or seizure disorders: - Government Buyer: - Federal Motor Carrier Safety Administration (FMCSA), Department of Transportation - OEMs and Vendors: - No OEMs or vendors are involved; this is a regulatory action, not a procurement - Products/Services Requested: - No products or services are being procured - The action renews exemptions for seven individuals to operate commercial motor vehicles (CMVs) in interstate commerce despite a history of epilepsy or seizures - Unique or Notable Requirements: - Exemptions are subject to strict terms, including: - Remaining seizure-free - Maintaining stable anti-seizure medication treatment - Undergoing annual medical examinations - Fulfilling reporting requirements - Complying with commercial driver license testing - FMCSA is seeking public comments on the renewal decision - Period of Performance: - Exemptions are valid for two years, with annual monitoring and reporting - Place of Performance: - FMCSA headquarters, Washington, DC

Description

The Federal Motor Carrier Safety Administration (FMCSA) announces the renewal of exemptions for seven individuals from the Federal Motor Carrier Safety Regulations that prohibit interstate commercial motor vehicle drivers from having a medical history or diagnosis of epilepsy or any condition likely to cause loss of consciousness. These exemptions allow individuals who have had seizures and are on anti-seizure medication to continue operating commercial motor vehicles in interstate commerce. The exemptions are renewed for a two-year period from April 15, 2026, to April 15, 2028, subject to specific terms and conditions including medical monitoring and reporting requirements. Public comments on the renewal are requested by June 8, 2026.

View original listing